FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/05/042419 [Registered on: 09/05/2022] Trial Registered Prospectively
Last Modified On: 08/05/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A comparative clinical study to evaluate the efficacy of Dashanga Kwatha and Nagara Ativishadi Kwatha in Hyperacidity  
Scientific Title of Study   A comparative clinical study to evaluate the efficacy of Dashanga Kwatha and Nagara Ativishadi Kwatha in the management of Urdhwaga Amlapitta  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mukul Shamrao Pawar 
Designation  M.D. Scholar Kayachikitsa 
Affiliation  MAMs Sumatibhai Shah Ayurved Mahavidyalaya, Malwadi, Hadapsar,Pune  
Address  Department Of Kayachikitsa, OPD Division, OPD no.2, Ground floor, Sane Guruji Arogya Kendra,Malwadi,Hadapsar,Pune

Pune
MAHARASHTRA
411028
India 
Phone  8149846431  
Fax    
Email  dr.mukulsp@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sachinkumar Sahebrao Patil 
Designation  Head Of Department Of Kayachikitsa 
Affiliation  MAMs Sumatibhai Shah Ayurved Mahavidyalaya, Malwadi, Hadapsar,Pune  
Address  Department Of Kayachikitsa, OPD Division, OPD no.2, Ground floor, Sane Guruji Arogya Kendra,Malwadi,Hadapsar,Pune

Pune
MAHARASHTRA
411028
India 
Phone  9822603608  
Fax    
Email  drsachinkumarpatil@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mukul Shamrao Pawar 
Designation  M.D. Scholar Kayachikitsa 
Affiliation  MAMs Sumatibhai Shah Ayurved Mahavidyalaya, Malwadi, Hadapsar,Pune  
Address  Department Of Kayachikitsa, OPD Division, OPD no.2, Ground floor, Sane Guruji Arogya Kendra,Malwadi,Hadapsar,Pune

Pune
MAHARASHTRA
411028
India 
Phone  8149846431  
Fax    
Email  dr.mukulsp@gmail.com  
 
Source of Monetary or Material Support  
MAMs Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune 
 
Primary Sponsor  
Name  Dr Mukul Shamrao Pawar 
Address  Department Of Kayachikitsa, OPD Division, OPD no.2, Ground floor, Sane Guruji Arogya Kendra,Malwadi,Hadapsar,Pune 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mukul Shamrao Pawar  Sane Guruji Arogya Kendra, Malwadi, Hadapsar, Pune  Department Of Kayachikitsa, OPD Division, OPD no.2, Ground floor, Sane Guruji Arogya Kendra,Malwadi,Hadapsar,Pune
Pune
MAHARASHTRA 
8149846431

dr.mukulsp@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K219||Gastro-esophageal reflux disease without esophagitis. Ayurveda Condition: URDHVAGATA-AMLAPITTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Nagara Ativishadi Kwatha, Reference: Kashyap samhita, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Madhyabhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Koshnajala), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Dashanga Kwatha, Reference: Bharat Bhaishajya Ratnakara, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Madhyabhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Koshnajala), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Age limit is from 18 to 60 years

irrespective of Gender, Occupation, Religion and

Economical condition.
2) Patients with at least 3 symptoms of Urdhwaga Amlapitta for more than 1-2 months will
be included according to Madhava Nidana (51/4-6)16 namely,
The symptoms of Amlapitta are as,
1. Chhardi (Vomiting)
2. Tikta-Amla-Udgara (Belching- Bitter/ Sour)
3. Kanthadaha (Burning sensation in throat)
4. Hruddaha (Burning sensation in the chest)
5. Kukshidaha (Burning sensation in the upper abdomen)
6. Shirashoola (Headache)
7. Hastapadadaha (Burning sensation in the palms and soles)
8. Aruchi (Loss of taste)
9. Utklesha/ Hrullasa (Nausea) 
 
ExclusionCriteria 
Details  1) Pregnant and Lactating women.
2) Patients with severe Vomiting and Diarrhoea and those who can’t take medicine orally.
3) Amlapitta along with other chronic disease and its associated complications.
4) Known case of Diabetes Mellitus. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the effect of Dashanga Kwatha with Nagara Ativishadi Kwatha  30 days 
 
Secondary Outcome  
Outcome  TimePoints 
To observe the adverse effect of Dashanga Kwatha and Nagara Ativishadi Kwatha  30 days  
 
Target Sample Size   Total Sample Size="66"
Sample Size from India="66" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/05/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    A comparative clinical study to evaluate the eficacy of Dashanga Kwatha  and Nagara Ativishadi Kwatha in Urdhwaga Amlapitta corelated with modern disease like GERD. Total 60 patients of Urdhwaga Amlapitta have been selected for the study divided in two groups. Dashanga Kwatha 20 ml BD at madhyabhakta kala will be given to patients included in  Group -A  for 30 days and Nagara Ativishadi Kwatha 20 ml BD at madhyabhakta kala will be given to patients included in Group-B for 30 days . 
Objectives of the study - To evaluate the comparative efficacy of Dashanga Kwatha and Nagara Ativishadi Kwatha in Urdhwaga Amlapitta .
The obtained results will be compared in between  two formulations and will be discussed accordingly. conclusion will be drawn based on overall assesment of data.
 
Close